$AKTX News

Akari Therapeutics CEO Highlights ASCO Data Demonstrating Synergy Of AKTX-101 With Adagasrib In KRAS-Driven Cancers In Virtual Investor "What This Means" Segment

Why Akari Therapeutics Stock Is Falling On Tuesday?

Akari Therapeutics Stock Jumps On Promising Preclinical Data

Akari Therapeutics' AKTX-101 Shows Synergistic Preclinical Cytotoxicity With KRAS Inhibitor In KRAS-Mutant Pancreatic Cancer Models, Highlighting RNA Splicing Payload Advantage

Akari Therapeutics Commences $5.5M Private Placement

Why Akari Therapeutics Stock Is Surging On Thursday?

Akari Therapeutics Granted European Patent For Proprietary ADC Payload Platform Technology

Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload

Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors

Akari Therapeutics Announces Abstract Acceptance For Online Publication At American Society Of Clinical Oncology Annual Meeting 2026

Maxim Sees High Risk Profile for Akari Therapeutics, plc (AKTX) Amid Capital Needs

Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing

Akari Therapeutics' AKTX-101 Shows Superior Preclinical Potency Versus Leading TROP2 ADCs Across Bladder, Lung, And Breast Cancer Models

Akari Therapeutics downgraded to Hold from Buy at Maxim

Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC

Maxim Group Downgrades Akari Therapeutics to Hold

Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing

Akari Therapeutics Collaborates With WuXi XDC Over Development Of Novel PH1 Payload

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending